Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Abundance of Relapse-Predictive Cells Can be Estimated at Diagnosis and Is Strongly Associated with Outcome in Pediatric AML

Mohammad Javad Najaf Panah, Alexandra McLean Stevens, Michael Krueger, Max P Rochette, Sohani K Sandhu, Lana E Kim, Joanna S. Yi, Tsz-Kwong Man, Michele S. Redell, Pavel Sumazin

Blood (2024) 144 (Supplement 1): 63.

https://doi.org/10.1182/blood-2024-206142

Published: 2024

Journal Articles

Optimizing Establishment of High Need Pediatric Acute Myeloid Leukemia Patient Derived Xenograft Models

Lana E Kim, Max P Rochette, Michele S. Redell, Alexandra McLean Stevens

Blood (2024) 144 (Supplement 1): 5780.

https://doi.org/10.1182/blood-2024-206067

Published: 2024

Journal Articles

Effects of Magrolimab Therapy in Conjunction with Conventional Chemotherapeutics in Pediatric Acute Myeloid Leukemia Patient Derived Xenograft Models

Sohani K Sandhu, Julia G Kim, Ritesh V Dontula, Joshua J Cooper, Jaden A Sherman, Max P Rochette, Lana E Kim, Michele S. Redell, Alexandra McLean Stevens

Blood (2024) 144 (Supplement 1): 4160.

https://doi.org/10.1182/blood-2024-199291

Published: 2024

Journal Articles

Molecular Features, Treatments and Outcomes for Pediatric AML Patients from APAL2020SC Pediatric Acute Leukemia (PedAL) Screening Trial

Michele S. Redell, Robert Gerbing, Todd A. Alonzo, Jim Wang, Maureen O'Brien, Sarah K. Tasian, Matthew A. Kutny, Todd M Cooper

Blood (2024) 144 (Supplement 1): 4233.

https://doi.org/10.1182/blood-2024-200978

Published: 2024

Journal Articles

APAL2020SC Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias

Michele S. Redell, Todd A. Alonzo, Robert Gerbing, Jim Wang, Maureen M. O'Brien, Gwen Nichols, Laura Di Laurenzio, Sarah K. Tasian, C. Michel Zwaan, Dirk Reinhardt, E. Anders Kolb, Todd Cooper

Blood (2023) 142 (Supplement 1): 1492.

https://doi.org/10.1182/blood-2023-190947

Published: 2023

Journal Articles

Project Evolve, Evaluation of Lineage Switch (LS), an International Initiative: Preliminary Results Reveal Dismal Outcomes in Patients with LS

Sara K. Silbert, Cynthia Harrison, D. Nathan Biery, Alexandra Semchenkova, Elena Zerkalenkova, Anna Alonso-Saladrigues, Kaylyn Utley, Ibrahim Aldoss, Liping Zhao, Sneha Fernandes, Jeremy D. Rubinstein, Naomi Torres Carapia, Bill H. Chang, Anant Vatsayan, Barbara De Moerloose, Holly L. Pacenta, Dennis John Kuo, Gabriele Escherich, Benjamin J. Lee, Michele S. Redell, Mandi R. Fitzjohn, Daniel P. Larson, Nicolas Duployez, Raymund S. Cuevo, Rui Rochelle He, David Dickens, Firas El Chaer, Kelly Reed, Matthias Wolfl, Sunil S. Raikar, Süreyya Savaşan, Latika Puri, Zhubin J. Gahvari, Aimee C. Talleur, Hisham Abdel-Azim, Aghiad Chamdin, Marlie R.M. Provost, Vanessa A. Fabrizio, Kerstin Mezger, Alexandra McLean Stevens, Emily M. Hsieh, Hao-Wei Wang, Constance M. Yuan, Ulrich A. Duffner, Jing Pan, Sara Ghorashian, Susana Rives, Chloe Hoang, Kara L. Davis, Elad Jacoby, Alexander Popov, Adam Lamble, Nirali N. Shah

Blood (2023) 142 (Supplement 1): 4202.

https://doi.org/10.1182/blood-2023-182293

Published: 2023

Journal Articles

Single Cell Transcriptome Comparisons of Diagnosis-Relapse Pairs Uncover Programs Associated with Chemoresistance in Pediatric AML

Mohammad Javad Najaf Panah, Tsz-Kwong Man, Michael Krueger, Pavel Sumazin, Michele S. Redell

Blood (2023) 142 (Supplement 1): 1574.

https://doi.org/10.1182/blood-2023-184926

Published: 2023

Journal Articles

Europeanpediatric Acute Leukemia (EuPAL) Registry

Katarzyna Majstrowicz, Katharina Waack, Evangelia Antoniou, Naghmeh Niktoreh, Gwen Nichols, Laura Di Laurenzio, Michele S. Redell, Todd Cooper, E. Anders Kolb, Sarah K. Tasian, Franco Locatelli, C. Michel Zwaan, Dirk Reinhardt

Blood (2023) 142 (Supplement 1): 1496.

https://doi.org/10.1182/blood-2023-189684

Published: 2023

Journal Articles

Improved Relapse Prediction in Pediatric Acute Myeloid Leukemia By Deconvolving Lineage-Specific and Cancer-Specific Features in Single-Cell Data

Timothy James Keyes, Astraea Jager, Michael Krueger, Sylvia Plevritis, Robert Tibshirani, Richard Aplenc, Garry P. Nolan, Michele S. Redell, Kara L. Davis

Blood (2022) 140 (Supplement 1): 6288–6289.

https://doi.org/10.1182/blood-2022-170939

Published: 2022

Journal Articles

Development of a Pediatric AML Patient Derived Xenograft Program

Alexandra McLean Stevens, Maci Terrell, Raushan Rashid, Jaime Omar Munoz, Alan K Gonzalez, Hailey H Oviedo, Tamilini Ilangovan, Michelle C Alozie, Michael Krueger, Kevin E. Fisher, Michele S. Redell

Blood (2022) 140 (Supplement 1): 11807–11808.

https://doi.org/10.1182/blood-2022-170348

Published: 2022

Journal Articles

Single-Cell Map of Childhood Acute Myeloid Leukaemia Using Variational Auto-Encoders

Alice Driessen, Susanne Unger, An-phi Nguyen, Stefanie Kreutmair, Chiara Alberti, Aakriti Sethi, Richard Aplenc, Michele S. Redell, Maria Rodriguez Martinez, Burkhard Becher

Blood (2022) 140 (Supplement 1): 2265–2266.

https://doi.org/10.1182/blood-2022-169468

Published: 2022

Journal Articles

Cite-Seq Reveals Distinct Patterns and Potential Mechanisms of Relapse in Pediatric AML

Tsz-Kwong Man, Mohammad Javad Najaf Panah, Jessica L. Elswood, Pavel Sumazin, Michele S. Redell

Blood (2021) 138 (Supplement 1): 3458.

https://doi.org/10.1182/blood-2021-152646

Published: 2021

Journal Articles

Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Collaboration

Blood (2021) 138 (Supplement 1): 1247.

https://doi.org/10.1182/blood-2021-147379

Published: 2021

Journal Articles

The Bone Marrow Environment Promotes Resistance to Mitoxantrone and Etoposide By Distinct Mechanisms in Pediatric AML

Xin Long, PhD, Michele S. Redell, MD PhD

Blood (2016) 128 (22): 3943.

https://doi.org/10.1182/blood.V128.22.3943.3943

Published: 2016

Journal Articles

Differential Expression of Adhesion Molecule Receptors May Influence Bone Marrow Microenvironment-Mediated Protection of Leukemia-Initiating Cells (LICs) in Infant MLL- rearranged ( MLL- R) Acute Lymphoblastic Leukemia (ALL)

Edward Allan R. Sison, MD, Amos S. Gaikwad, PhD, Gaye Jenkins, Terzah M. Horton, MD PhD, Patrick Brown, MD, Michele S. Redell, MD PhD

Blood (2016) 128 (22): 1585.

https://doi.org/10.1182/blood.V128.22.1585.1585

Published: 2016

Journal Articles

Interleukin-6 Levels Predict Relapse Free Survival in Pediatric AML and Suggest a Mechanism of Chemotherapy Resistance

Alexandra M. Stevens, MD, Jennifer K Mehl, MD, Pavel Sumazin, PhD, Michele S. Redell, MD PhD

Blood (2016) 128 (22): 1724.

https://doi.org/10.1182/blood.V128.22.1724.1724

Published: 2016

Journal Articles

Rapid Infusion of Rituximab Is Well Tolerated in Children with Hematologic, Oncologic, and Rheumatologic Disorders

Amanda Bell Grimes, MD, Marietta M DeGuzman, MD, Jessica Poehls, PharmD, Taylor Olmsted, MD, Rachel Beaty Carroll, PharmD, Michele S Redell, MD PhD, Susan E. Kirk, PA-C, Charles G Minard, PhD, Melanie Brooke Bernhardt, PharmD, MS, Jenny M. Despotovic, DO, MS

Blood (2016) 128 (22): 2329.

https://doi.org/10.1182/blood.V128.22.2329.2329

Published: 2016

Journal Articles

A STAT3 decoy lures AML out of hiding

Michele S. Redell

Blood (2016) 127 (13): 1628–1629.

https://doi.org/10.1182/blood-2016-02-695452

Published: 2016

Journal Articles

Poorer Relapse-Free Survival in Hispanic Children Diagnosed with Acute Myeloid Leukemia Compared with Non-Hispanics: A Texas Single Institution Experience

Aditya Deshpande, Maria Monica Gramatges, MD PhD, Ghadir S. Sasa, MD, Philip J Lupo, PhD MPH, Rachel E Rau, MD, Michele S. Redell, MD PhD, Terzah M. Horton, MD PhD, Michael E Scheurer, PhD MPH, Karen R. Rabin, MD PhD

Blood (2015) 126 (23): 1312.

https://doi.org/10.1182/blood.V126.23.1312.1312

Published: 2015

Journal Articles

A Novel STAT3 Inhibitor Has Potent Activity in Preclinical Models of Acute Myeloid Leukemia That Incorporate the Stromal Environment

Michael J Krueger, BS, Matthew Minus, BS, Wei Liu, PhD, Xin Long, PhD, Alexandra M. Stevens, MD, Mikhail I. Kolosov, BS, Edward Allan R. Sison, MD, David John Tweardy, MD, Zachary T. Ball, PhD, Michele S. Redell, MD PhD

Blood (2015) 126 (23): 569.

https://doi.org/10.1182/blood.V126.23.569.569

Published: 2015

NARROW

Abundance of Relapse-Predictive Cells Can be Estimated at Diagnosis and Is Strongly Associated with Outcome in Pediatric AML

Optimizing Establishment of High Need Pediatric Acute Myeloid Leukemia Patient Derived Xenograft Models

Effects of Magrolimab Therapy in Conjunction with Conventional Chemotherapeutics in Pediatric Acute Myeloid Leukemia Patient Derived Xenograft Models

Molecular Features, Treatments and Outcomes for Pediatric AML Patients from APAL2020SC Pediatric Acute Leukemia (PedAL) Screening Trial

APAL2020SC Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias

Project Evolve, Evaluation of Lineage Switch (LS), an International Initiative: Preliminary Results Reveal Dismal Outcomes in Patients with LS

Single Cell Transcriptome Comparisons of Diagnosis-Relapse Pairs Uncover Programs Associated with Chemoresistance in Pediatric AML

Europeanpediatric Acute Leukemia (EuPAL) Registry

Improved Relapse Prediction in Pediatric Acute Myeloid Leukemia By Deconvolving Lineage-Specific and Cancer-Specific Features in Single-Cell Data

Development of a Pediatric AML Patient Derived Xenograft Program

Single-Cell Map of Childhood Acute Myeloid Leukaemia Using Variational Auto-Encoders

Cite-Seq Reveals Distinct Patterns and Potential Mechanisms of Relapse in Pediatric AML

Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Collaboration

The Bone Marrow Environment Promotes Resistance to Mitoxantrone and Etoposide By Distinct Mechanisms in Pediatric AML

Differential Expression of Adhesion Molecule Receptors May Influence Bone Marrow Microenvironment-Mediated Protection of Leukemia-Initiating Cells (LICs) in Infant MLL- rearranged ( MLL- R) Acute Lymphoblastic Leukemia (ALL)

Interleukin-6 Levels Predict Relapse Free Survival in Pediatric AML and Suggest a Mechanism of Chemotherapy Resistance

Rapid Infusion of Rituximab Is Well Tolerated in Children with Hematologic, Oncologic, and Rheumatologic Disorders

A STAT3 decoy lures AML out of hiding

Poorer Relapse-Free Survival in Hispanic Children Diagnosed with Acute Myeloid Leukemia Compared with Non-Hispanics: A Texas Single Institution Experience

A Novel STAT3 Inhibitor Has Potent Activity in Preclinical Models of Acute Myeloid Leukemia That Incorporate the Stromal Environment

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only